Colgate-Palmolive (NYSE:CL) Price Target Raised to $97.00 at JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) had its price objective raised by JPMorgan Chase & Co. from $93.00 to $97.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other equities analysts have also commented on CL. Barclays set a $83.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 16th. Jefferies Financial Group set a $85.00 target price on shares of Colgate-Palmolive in a research note on Tuesday, December 16th. The Goldman Sachs Group restated a “buy” rating and set a $94.00 price target on shares of Colgate-Palmolive in a research report on Saturday. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research report on Tuesday, December 9th. Finally, Wells Fargo & Company boosted their target price on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Sunday. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $94.13.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $91.75 on Monday. The firm has a market capitalization of $73.96 billion, a P/E ratio of 35.02, a PEG ratio of 6.09 and a beta of 0.29. Colgate-Palmolive has a one year low of $74.54 and a one year high of $100.18. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The business has a fifty day moving average price of $81.02 and a 200-day moving average price of $81.37.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. During the same quarter in the prior year, the firm posted $0.91 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s payout ratio is 79.39%.

Hedge Funds Weigh In On Colgate-Palmolive

A number of large investors have recently modified their holdings of CL. Westside Investment Management Inc. raised its stake in shares of Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares in the last quarter. Maseco LLP purchased a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $27,000. Copia Wealth Management bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $29,000. Vermillion & White Wealth Management Group LLC raised its position in Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the period. Finally, Cloud Capital Management LLC purchased a new position in Colgate-Palmolive in the 3rd quarter worth $30,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Large-cap brokers raised targets/ratings — Bank of America moved its target to $100 and kept a Buy rating (about ~9% upside), signaling confidence in the company’s growth drivers. Bank of America raises PT to $100
• Positive Sentiment: Evercore lifted its target to $100 and set an Outperform rating, another high-profile shop adding upside to consensus. Evercore raises PT to $100
• Positive Sentiment: JPMorgan raised its price target to $97 and put CL at Overweight, adding institutional weight behind the post-earnings view. JPMorgan raises PT to $97
• Positive Sentiment: Colgate reported Q4 results that beat estimates (EPS $0.95 vs. $0.91 expected; revenue $5.23B vs. $5.13B expected) and organic sales growth, which prompted analysts to boost forecasts. Earnings strength is the primary catalyst for the upgrades. Analysts Boost Forecasts After Q4 Beat
• Positive Sentiment: Sell-side commentary (TD Cowen, Bank of America research notes) emphasizes premiumization, emerging-market strength and pet nutrition as multi-year growth levers supporting Buy ratings. Analyst thematic support
• Neutral Sentiment: Jefferies raised its target modestly to $91 but keeps a Hold rating; the new target is near the current price, implying limited near-term upside. Jefferies raises PT to $91 (Hold)
• Neutral Sentiment: Deutsche Bank raised its target to $90 and remains a Hold, another signal that some shops see less immediate upside despite the beat. Deutsche Bank raises PT to $90
• Negative Sentiment: Press coverage highlights lingering consumer uncertainty that could pressure volumes/mix going forward, a reminder that macro headwinds remain despite the beat. Consumer uncertainty clouds outlook

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.